Entity Public Float of ORAMED PHARMACEUTICALS INC. from 29 Feb 2012 to 30 Jun 2024

Taxonomy & unit
dei: USD
Description
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary
ORAMED PHARMACEUTICALS INC. quarterly Entity Public Float in USD history and change rate from 29 Feb 2012 to 30 Jun 2024.
  • ORAMED PHARMACEUTICALS INC. Entity Public Float for the quarter ending 30 Jun 2024 was $131,190,607, a 0.51% increase year-over-year.
Source SEC data
View on sec.gov
Entity Public Float, Quarterly (USD)
Entity Public Float, YoY Quarterly Change (%)

ORAMED PHARMACEUTICALS INC. Quarterly Entity Public Float (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $131,190,607 +$665,085 +0.51% 30 Jun 2024 10-K/A 16 Jul 2025 2024 FY
Q2 2023 $130,525,522 -$39,068,827 -23% 30 Jun 2023 10-K 06 Mar 2024 2023 FY
Q2 2022 $169,594,349 30 Jun 2022 10-K 06 Mar 2023 2022 FY
Q1 2021 $227,769,778 +$166,968,924 +275% 28 Feb 2021 10-K 24 Nov 2021 2021 FY
Q1 2020 $60,800,854 +$18,289,452 +43% 29 Feb 2020 10-K 24 Nov 2020 2020 FY
Q1 2019 $42,511,402 -$31,891,049 -43% 28 Feb 2019 10-K 27 Nov 2019 2019 FY
Q1 2018 $74,402,451 +$17,653,608 +31% 28 Feb 2018 10-K 28 Nov 2018 2018 FY
Q1 2017 $56,748,843 -$16,827,944 -23% 28 Feb 2017 10-K 29 Nov 2017 2017 FY
Q1 2016 $73,576,787 +$29,107,603 +65% 29 Feb 2016 10-K 25 Nov 2016 2016 FY
Q1 2015 $44,469,184 -$84,437,081 -66% 28 Feb 2015 10-K 25 Nov 2015 2015 FY
Q1 2014 $128,906,265 +$76,212,237 +145% 28 Feb 2014 10-K 14 Nov 2014 2014 FY
Q1 2013 $52,694,028 +$35,201,442 +201% 28 Feb 2013 10-K 27 Nov 2013 2013 FY
Q1 2012 $17,492,586 29 Feb 2012 10-K 12 Dec 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.